TWiV 872: COVID-19 clinical update #104 with Dr. Daniel Griffin episode artwork

EPISODE · Mar 5, 2022 · 56 MIN

TWiV 872: COVID-19 clinical update #104 with Dr. Daniel Griffin

from This Week in Virology · host Vincent Racaniello

In COVID-19 clinical update #104, Daniel Griffin reviews effectiveness of mRNA vaccines among children, number of children affected by disease, accuracy of rapid antigen tests, CDC guidance for prevention strategies, monoclonal antibody effectiveness, predicting progression to severe respiratory failure from pneumonia, risk of long COVID after two vaccine doses, and peripheral neuropathy in long COVID. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Vaccine effectiveness 5-11 year olds (medRxiv) Vaccine effectiveness vs ED and UCE 5-12 year olds (medRxiv) Children affected by COVID (Lancet) Accuracy of rapid antigen tests (medRxiv) COVID community levels (CDC) Therapeutics guidelines (WHO) Mortality among SOT (Clin Inf Dis) Long COVID after two vaccine doses (medRxiv) Peripheral neuropathy in COVID patients (Neurology) Letters read on TWiV 872 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

Episode metadata supplied by the publisher feed · Published Mar 5, 2022

Embed this episode

NOW PLAYING

TWiV 872: COVID-19 clinical update #104 with Dr. Daniel Griffin

0:00 56:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Week in Virology?

This episode is 56 minutes long.

When was this This Week in Virology episode published?

This episode was published on March 5, 2022.

Can I download this This Week in Virology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!